| 000116 (2015) |
N. Hermann [Autriche] | [Effectiveness of Live Attenuated Influenza Vaccines and Trivalent Inactivated Influenza Vaccines against confirmed Influenza In Children and Adolescents in Saxony-Anhalt, 2012/13]. |
| 000042 (2018) |
A. Möhl [Allemagne] ; L. Gr Fe [Allemagne] ; C. Helmeke [Allemagne] ; D. Ziehm [Allemagne] ; M. Monazahian [Allemagne] ; H-M Irmscher [Allemagne] ; J. Dreesman [Allemagne] | Estimating vaccine effectiveness against laboratory-confirmed influenza among children and adolescents in Lower Saxony and Saxony-Anhalt, 2012-2016. |
| 000126 (2015) |
Oliver Damm [Allemagne] ; Martin Eichner ; Markus Andreas Rose ; Markus Knuf ; Peter Wutzler ; Johannes Günter Liese ; Hagen Krüger ; Wolfgang Greiner | Public health impact and cost-effectiveness of intranasal live attenuated influenza vaccination of children in Germany. |
| 000134 (2015) |
Carina Helmeke [Allemagne] ; Lutz Gr Fe [Allemagne] ; Hanns-Martin Irmscher [Allemagne] ; Constanze Gottschalk [Allemagne] ; Ioannis Karagiannis [Suède] ; Hanna Oppermann [Allemagne] | Effectiveness of the 2012/13 trivalent live and inactivated influenza vaccines in children and adolescents in Saxony-Anhalt, Germany: a test-negative case-control study. |
| 000210 (2013) |
H. Englund [Allemagne] ; H. Campe ; W. Hautmann | Effectiveness of trivalent and monovalent influenza vaccines against laboratory-confirmed influenza infection in persons with medically attended influenza-like illness in Bavaria, Germany, 2010/2011 season. |
| 000157 (2014) |
Markus A. Rose ; Oliver Damm ; Wolfgang Greiner ; Markus Knuf ; Peter Wutzler ; Johannes G. Liese ; Hagen Krüger ; Ulrich Wahn ; Tom Schaberg ; Markus Schwehm ; Thomas F. Kochmann ; Martin Eichner [Allemagne] | The epidemiological impact of childhood influenza vaccination using live-attenuated influenza vaccine (LAIV) in Germany: predictions of a simulation study. |
| 000195 (2013) |
S. Grund [Allemagne] ; O. Wichmann ; T. Mertens ; H. Hengel | [Concepts, effectiveness, and perspectives of pandemic and seasonal influenza vaccines]. |
| 000215 (2013) |
G. Falkenhorst [Allemagne] ; T. Harder ; C. Remschmidt ; M. Terhardt ; F. Zepp ; T. Ledig ; S. Wicker ; B. Keller-Stanislawski ; T. Mertens | Background paper to the recommendation for the preferential use of live-attenuated influenza vaccine in children aged 2-6 years in Germany. |
| 000251 (2012) |
Anna K. Lugnér [Pays-Bas] ; Michiel Van Boven ; Robin De Vries ; Maarten J. Postma ; Jacco Wallinga | Cost effectiveness of vaccination against pandemic influenza in European countries: mathematical modelling analysis. |
| 000279 (2011) |
P. Maksimov [Allemagne] ; S. Buschtöns ; D C Herrmann ; F J Conraths ; K. Görlich ; A M Tenter ; J P Dubey ; U. Nagel-Kohl ; B. Thoms ; L. Bötcher ; M. Kühne ; G. Schares | Serological survey and risk factors for Toxoplasma gondii in domestic ducks and geese in Lower Saxony, Germany. |
| 000466 (2006) |
K. Beyrer [Allemagne] ; J. Dreesman ; R. Heckler ; K. Bradt ; H. Scharlach ; A. Baillot ; M. Monazahian ; D. Tabeling ; I. Holle ; M. Pulz ; A. Windorfer | [Surveillance of acute respiratory illnesses (ARI) in Lower Saxony: first experience from the years 2005-2006]. |
| 000523 (2003) |
R. Rychlik [Allemagne] ; T. Heinen-Kammerer ; H. Rusche ; J. Piercy ; P. Scuffham ; Y. Zöllner | [Cost-effectiveness of prophylaxis and treatment of influenza]. |
| 000601 (1964) |
G. Starke ; I. Siebelist ; E. Hiller | [INVESTIGATIONS ON THE PROBLEM OF THE DETECTION OF LIVE INFLUENZA VACCINES. I. RESULTS OF A TEST OF LIVE A2-INFLUENZA-VACCINES IN A CONTROLLED EXPERIMENT WITH VOLUNTEERS]. |
| 000628 (????) |
Samuel Aballéa [Royaume-Uni] ; Jeremy Chancellor ; Monique Martin ; Peter Wutzler ; Fabrice Carrat ; Roberto Gasparini ; Joao Toniolo-Neto ; Michael Drummond ; Milton Weinstein | The cost-effectiveness of influenza vaccination for people aged 50 to 64 years: an international model. |
| 000009 (2019) |
Ralf Wagner [Allemagne] ; Eberhard Hildt [Allemagne] | [Composition and mode of action of adjuvants in licensed viral vaccines]. |
| 000016 (2019) |
Stefan Scholz [Allemagne] ; Oliver Damm [Allemagne] ; Udo Schneider [Allemagne] ; Bernhard Ultsch [Allemagne] ; Ole Wichmann [Allemagne] ; Wolfgang Greiner [Allemagne] | Epidemiology and cost of seasonal influenza in Germany - a claims data analysis. |
| 000036 (2018) |
Evelyne Kretzschmar [Allemagne] ; Heide Muckenfuss [Allemagne] ; Michael Pfleiderer [Allemagne] | Official batch control of influenza vaccines: Is it still useful? |
| 000062 (2017) |
Seong-Su Yuk [Corée du Sud] ; T O Erdene-Ochir [Corée du Sud] ; Jung-Hoon Kwon [Corée du Sud] ; Jin-Yong Noh [Corée du Sud] ; Woo-Tack Hong [Corée du Sud] ; Jei-Hyun Jeong [Corée du Sud] ; Sol Jeong [Corée du Sud] ; Gyeong-Bin Gwon [Corée du Sud] ; Jong-Il Shin [Corée du Sud] ; Jung-Hyang Sur [Corée du Sud] ; Chang-Seon Song [Corée du Sud] | Efficacy of clade 2.3.2 H5 commercial vaccines in protecting chickens from clade 2.3.4.4 H5N8 highly pathogenic avian influenza infection. |
| 000084 (2016) |
Birgitta Weltermann [Allemagne] ; Anna Herwig [Allemagne] ; Dorothea Dehnen [Allemagne] ; Kerstin Herzer [Allemagne] | Vaccination Status of Pneumococcal and Other Vaccines in 444 Liver Transplant Patients Compared to a Representative Population Sample. |
| 000098 (2016) |
Christiaan Dolk [Pays-Bas] ; Martin Eichner [Allemagne] ; Robert Welte [Allemagne] ; Anastassia Anastassopoulou [Allemagne] ; Laure-Anne Van Bellinghen [Belgique] ; Barbara Poulsen Nautrup [Allemagne] ; Ilse Van Vlaenderen [Belgique] ; Ruprecht Schmidt-Ott [Allemagne, Belgique] ; Markus Schwehm [Allemagne] ; Maarten Postma [Pays-Bas] | Cost-Utility of Quadrivalent Versus Trivalent Influenza Vaccine in Germany, Using an Individual-Based Dynamic Transmission Model. |
| 000110 (2015) |
Peter Wutzler [Allemagne] ; Brigitte Dietz ; Roland Hardt ; Lutz Hoins ; Markus Knuf ; Klaus Wahle | [Quadrivalent influenza vaccines]. |
| 000136 (2015) |
Birgit Ehlken [Allemagne] ; Anastassia Anastassopoulou [Allemagne] ; Johannes Hain [Allemagne] ; Claudia Schröder [Allemagne] ; Klaus Wahle [Allemagne] | Cost for physician-diagnosed influenza and influenza-like illnesses on primary care level in Germany--results of a database analysis from May 2010 to April 2012. |
| 000144 (2015) |
Cornelius Remschmidt [Allemagne] ; Thorsten Rieck [Allemagne] ; Birte Bödeker [Allemagne] ; Ole Wichmann [Allemagne] | Application of the screening method to monitor influenza vaccine effectiveness among the elderly in Germany. |
| 000154 (2014) |
J. Barth ; T. Hammerschmidt [Allemagne] ; J. Vollmar [Allemagne] ; M. Bierbaum ; O. Schöffski | [Mechanics and effects of European reference pricing for vaccines in Germany according to §130a Abs. 2 SGB V: an analysis using the example of influenza vaccines]. |
| 000233 (2012) |
Wiebke Hellenbrand [Allemagne] ; Pernille Jorgensen ; Brunhilde Schweiger ; Gerhard Falkenhorst ; Matthias Nachtnebel ; Benedikt Greutélaers ; Christian Traeder ; Ole Wichmann | Prospective hospital-based case-control study to assess the effectiveness of pandemic influenza A(H1N1)pdm09 vaccination and risk factors for hospitalization in 2009-2010 using matched hospital and test-negative controls. |
| 000256 (2012) |
Patricia R. Blank [Suisse] ; Genevieve Bonnelye ; Aurore Ducastel ; Thomas D. Szucs | Attitudes of the general public and general practitioners in five countries towards pandemic and seasonal influenza vaccines during season 2009/2010. |
| 000270 (2011) |
R. Allwinn [Allemagne] ; H W Doerr | [Comparison of seasonal influenza vaccines: composition and properties]. |
| 000292 (2011) |
J. Garcia-Sicilia [Espagne] ; P. Gillard ; A. Carmona ; J C Tejedor ; J. Aristegui ; J M Merino ; U. Behre ; A. Caplanusi ; T. Vaman ; I. Dieussaert | Immunogenicity and safety of AS03-adjuvanted H1N1 pandemic vaccines in children and adolescents. |
| 000296 (2011) |
Helmut Uphoff [Allemagne] ; Matthias An Der Heiden ; Brunhilde Schweiger ; Hartmut Campe ; Dietmar Beier ; Carina Helmeke ; Martina Littmann ; Walter Haas ; Silke Buda ; Daniel Faensen ; Marcel Feig ; Doris Altmann ; Ole Wichmann ; Tim Eckmanns ; Udo Buchholz | Effectiveness of the AS03-adjuvanted vaccine against pandemic influenza virus A/(H1N1) 2009--a comparison of two methods; Germany, 2009/10. |
| 000311 (2010) |
J. Löwer [Allemagne] | [Pandemic influenza vaccines. How should they be designed?]. |
| 000320 (2010) |
J. Hauswaldt [Allemagne] ; M. Kersting ; E. Hummers-Pradier | [Influenza vaccination by Lower Saxonian general practitioners - a secondary analysis of physicians' data from 1995/1996, 2002/2003, and 2005/2006]. |
| 000334 (2010) |
O. Wichmann [Allemagne] ; P. Stocker ; G. Poggensee ; D. Altmann ; D. Walter ; W. Hellenbrand ; G. Krause ; T. Eckmanns | Pandemic influenza A(H1N1) 2009 breakthrough infections and estimates of vaccine effectiveness in Germany 2009-2010. |
| 000404 (2009) |
H. Melzl [Allemagne] ; J J Wenzel ; B. Kochanowski ; K. Feierabend ; B. Kreuzpaintner ; E. Kreuzpaintner ; A. Rohrhofer ; S. Schreder-Meindl ; H. Wollner ; B. Salzberger ; U. Reischl ; W. Jilg ; H. Wolf ; H H Niller | First sequence-confirmed case of infection with the new influenza A(H1N1) strain in Germany. |
| 000448 (2007) |
J. Bürger [Allemagne] | [Development of vaccines against the next pandemic influenza virus]. |
| 000471 (2006) |
H. Uphoff [Allemagne] ; A M Hauri ; B. Schweiger ; R. Heckler ; W. Haas ; A. Grüber ; U. Buchholz | [Estimation of influenza vaccine effectiveness using routine surveillance data]. |
| 000500 (2005) |
| Establishment of vaccination clinics; user fees for investigational new drug (IND) influenza vaccine services and vaccines. Interim final rule and request for comments. |
| 000501 (2005) |
Birgit Ehlken [Allemagne] ; Gabriele Ihorst ; Barbara Lippert ; Angela Rohwedder ; Gudula Petersen ; Martin Schumacher ; Johannes Forster | Economic impact of community-acquired and nosocomial lower respiratory tract infections in young children in Germany. |
| 000509 (2004) |
Eric Neumayer [Royaume-Uni] | Recessions lower (some) mortality rates: evidence from Germany. |
| 000545 (2001) |
T. Szucs [Suisse] ; M. Behrens ; T. Volmer | [Public health costs of influenza in Germany 1996- a cost-of-illness analysis]. |
| 000551 (2001) |
W. Jilg [Allemagne] | [Adults tired of vaccines. Ask your patients about vaccine protection!]. |
| 000560 (1999) |
S. Heinzl | [Cost factors of influenza]. |
| 000623 (????) |
Theodore J D. Knight-Jones [Royaume-Uni] ; Ruth Hauser ; Doris Matthes ; Katharina D C. St Rk | Evaluation of effectiveness and efficiency of wild bird surveillance for avian influenza. |
